Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ameren (AEE) EBITDA (2016 - 2025)

Historic EBITDA for Ameren (AEE) over the last 17 years, with Q3 2025 value amounting to $641.0 million.

  • Ameren's EBITDA rose 4057.02% to $641.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year increase of 2473.5%. This contributed to the annual value of $1.2 billion for FY2024, which is 303.82% up from last year.
  • Per Ameren's latest filing, its EBITDA stood at $641.0 million for Q3 2025, which was up 4057.02% from $273.0 million recorded in Q2 2025.
  • In the past 5 years, Ameren's EBITDA registered a high of $641.0 million during Q3 2025, and its lowest value of $139.0 million during Q4 2021.
  • In the last 5 years, Ameren's EBITDA had a median value of $258.0 million in 2024 and averaged $295.4 million.
  • Within the past 5 years, the most significant YoY rise in Ameren's EBITDA was 5838.93% (2021), while the steepest drop was 1516.39% (2021).
  • Over the past 5 years, Ameren's EBITDA (Quarter) stood at $139.0 million in 2021, then increased by 7.19% to $149.0 million in 2022, then increased by 5.37% to $157.0 million in 2023, then surged by 35.03% to $212.0 million in 2024, then skyrocketed by 202.36% to $641.0 million in 2025.
  • Its EBITDA stands at $641.0 million for Q3 2025, versus $273.0 million for Q2 2025 and $286.0 million for Q1 2025.